Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein

Brain Research

Volumn 1022, Issue 1-2, 2004, Pages 30-38

  Wen, Yi ^a   Yang, Shaohua ^a   Liu, Ran ^a   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Cerebral ischemia; Hyperphosphorylation; Tau protein

Indexed keywords

TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL DEATH; DISEASE MODELS, ANIMAL; FEMALE; FRONTAL LOBE; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDOLES; ISCHEMIC ATTACK, TRANSIENT; NERVE TISSUE PROTEINS; NEURONS; PHOSPHORYLATION; RATS; TAU PROTEINS; TETRAZOLIUM SALTS;

EID: 4444333265     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.05.106     Document Type: Article

References (61)

1. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719
2. Augustinack J.C., Schneider A., Mandelkow E.M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. (Berl.). 103:2002;26-35
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476
4. Behl C. Apoptosis and Alzheimer's disease. J. Neural Transm. 107:2000;1325-1344
5. Behl C., Moosmann B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol. Chem. 383:2002;521-536
6. Biernat J., Gustke N., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11:1993;153-163
7. Billingsley M.L., Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323(Pt 3):1997;577-591
8. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099
9. Bremer A.M., Watanabe O., Bourke R.S. Artificial embolization of the middle cerebral artery in primates. Description of an experimental model with extracranial technique. Stroke. 6:1975;387-390
10. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33:2000;95-130
11. Burkhart K.K., Beard D.C., Lehman R.A., Billingsley M.L. Alterations in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp. Neurol. 154:1998;464-472
12. Cleveland D.W., Hwo S.Y., Kirschner M.W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116:1977;207-225
13. Contois J.H., Anamani D.E., Tsongalis G.J. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. Clin. Lab. Med. 16:1996;105-123
14. Cotman C.W., Su J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6:1996;493-506
15. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron. 40:2003;471-483
16. Dewar D., Graham D.I., Teasdale G.M., McCulloch J. Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. Acta Neuropathol. (Berl.). 86:1993;623-629
17. Drechsel D.N., Hyman A.A., Cobb M.H., Kirschner M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 3:1992;1141-1154
18. Ferrari A., Hoerndli F., Baechi T., Nitsch R.M., Gotz J. Beta-amyloid induces paired helical filament-like tau filaments in tissue culture. J. Biol. Chem. 278:2003;40162-40168
19. Gasparini L., Netzer W.J., Greengard P., Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23:2002;288-293
20. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 85:1988;4051-4055
21. Goedert M., Jakes R., Spillantini M.G., Crowther R.A., Cohen P., Vanmechelen E., Probst A., Gotz J., Burki K. Tau protein in Alzheimer's disease. Biochem. Soc. Trans. 23:1995;80-85
22. Gotz J., Chen F., Barmettler R., Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276:2001;529-534
23. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 293:2001;1491-1495
24. Ikeda K., Akiyama H., Arai T., Kondo H., Haga C., Tsuchiya K., Yamada S., Murayama S., Hori A. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain? Neurosci. Lett. 284:2000;187-189
25. James N.D., Davis D.R., Sindon J., Hanger D.P., Brion J.P., Miller C.C., Rosenberg M.P., Anderton B.H., Propst F. Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos. Neurobiol. Aging. 17:1996;235-241
26. Jicha G.A., Bowser R., Kazam I.G., Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48:1997;128-132
27. Kanai Y., Takemura R., Oshima T., Mori H., Ihara Y., Yanagisawa M., Masaki T., Hirokawa N. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J. Cell Biol. 109:1989;1173-1184
28. Kanemaru K., Takio K., Miura R., Titani K., Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J. Neurochem. 58:1992;1667-1675
29. Kobayashi K., Nakano H., Hayashi M., Shimazaki M., Fukutani Y., Sasaki K., Sugimori K., Koshino Y. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J. Neurol. Sci. 208:2003;17-24
30. Kondo J., Honda T., Mori H., Hamada Y., Miura R., Ogawara M., Ihara Y. The carboxyl third of tau is tightly bound to paired helical filaments. Neuron. 1:1988;827-834
31. Kosik K.S., Orecchio L.D., Binder L., Trojanowski J.Q., Lee V.M., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron. 1:1988;817-825
32. Lee M.S., Tsai L.H. Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimer's Dis. 5:2003;127-137
33. Lee V.M., Balin B.J., Otvos L. Jr., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 251:1991;675-678
34. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491
35. Li Y., Chopp M., Powers C., Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res. 765:1997;301-312
36. Loeb C., Gandolfo C., Croce R., Conti M. Dementia associated with lacunar infarction. Stroke. 23:1992;1225-1229
37. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 399:1999;784-788
38. Maccioni R.B., Munoz J.P., Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch. Med. Res. 32:2001;367-381
39. Mailliot C., Podevin-Dimster V., Rosenthal R.E., Sergeant N., Delacourte A., Fiskum G., Buee L. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J. Cereb. Blood Flow. Metab. 20:2000;543-549
40. Neve R.L., Harris P., Kosik K.S., Kurnit D.M., Donlon T.A. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res. 387:1986;271-280
41. Papasozomenos S.C., Su Y. Altered phosphorylation of tau protein in heat-shocked rats and patients with Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4543-4547
42. Pasquier F., Leys D. Why are stroke patients prone to develop dementia? J. Neurol. 244:1997;135-142
43. Perez M., Cuadros R., Smith M.A., Perry G., Avila J. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett. 486:2000;270-274
44. Perez M., Hernandez F., Gomez-Ramos A., Smith M., Perry G., Avila J. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur. J. Biochem. 269:2002;1484-1489
45. Perry G., Nunomura A., Lucassen P., Lassmann H., Smith M.A. Apoptosis and Alzheimer's disease. Science. 282:1998;1268-1269
46. Sanchez M.P., Alvarez-Tallada V., Avila J. The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies. Rev. Neurol. 33:2001;169-177
47. Schneider A., Biernat J., von Bergen M., Mandelkow E., Mandelkow E.M. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry. 38:1999;3549-3558
48. Shackelford D.A., Yeh R.Y. Dephosphorylation of tau during transient forebrain ischemia in the rat. Mol. Chem. Neuropathol. 34:1998;103-120
49. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 853:2000;1-4
50. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87:1997;724-730
51. Slater A.F., Stefan C., Nobel I., van den Dobbelsteen D.J., Orrenius S. Signalling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82-83:1995;149-153
52. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657
53. Spillantini M.G., Goedert M., Jakes R., Klug A. Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3947-3951
54. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533
55. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., Remien R.H., Williams J.B., Mohr J.P., Hauser W.A., et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 42:1992;1185-1193
56. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Stern Y., Sano M., Hauser W.A., Mayeux R. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 44:1994;1885-1891
57. Trojanowski J.Q., Lee V.M. Paired helical filament tau in Alzheimer's disease. The kinase connection. Am. J. Pathol. 144:1994;449-453
58. Weingarten M.D., Lockwood A.H., Hwo S.Y., Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U. S. A. 72:1975;1858-1862
59. Wise P.M. Estrogens and neuroprotection. Trends Endocrinol. Metab. 13:2002;229-230
60. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology. 142:2001;969-973
61. Yankner B.A. New clues to Alzheimer's disease: unraveling the roles of amyloid and tau. Nat. Med. 2:1996;850-852